Literature DB >> 15466403

Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate.

Ryan P McCarthy1, Shaobo Zhang, David G Bostwick, Junqi Qian, John N Eble, Mingsheng Wang, Haiqun Lin, Liang Cheng.   

Abstract

Phyllodes tumor of the prostate is a rare neoplasm, composed of epithelium-lined cysts and channels embedded in a variably cellular stroma. The pathogenetic relationship of the epithelium and stroma is unknown and whether each is a clonal neoplastic element is uncertain. We studied the clonality of phyllodes tumors from six patients who underwent either enucleation or transurethral resection as their initial treatment. This was followed by total prostatectomy in three of the patients. Laser-assisted microdissection was performed to extract epithelial and stromal components of phyllodes tumor from formalin-fixed, paraffin-embedded tissue. Polymerase chain reaction was used to amplify genomic DNA at specific loci on chromosome 7q31 (D7S522), 8p21.3-q11.1 (D8S133, D8S137), 8p22 (D8S261), 10q23 (D10S168, D10S571), 17p13 (TP53), 16q23.2 (D16S507), 12q11-12 (D12S264), 17q (D17S855), 18p11.22-p11 (D18S53), and 22q11.2 (D22S264). In each tumor, stroma and epithelium were analyzed separately. Gel electrophoresis with autoradiography was used to detect loss of heterozygosity. All tumors showed allelic loss in one or more loci of both the epithelial and stromal components. The frequency of allelic loss in the epithelial component was 2 of 5 (40%) at D7S522, 2 of 6 (33%) at D8S133, 1 of 5 (20%) at D8S137, 3 of 6 (50%) at D8S261, 4 of 4 (100%) at D10S168, 4 of 6 (67%) at TP53, 2 of 6 (33%) at D10S571, 6 of 6 (100%) at D16S507, 1 of 5 (20%) at D12S264, 1 of 6 (17%) at D17S855, 2 of 6 (33%) at D18S53, and 2 of 5 (40%) at D22S264. The frequency of allelic loss in the stromal component was 2 of 5 (40%) at D7S522, 1 of 6 (17%) at D8S133, 2 of 5 (40%) at D8S137, 3 of 6 (50%) at D8S261, 1 of 4 (25%) at D10S168, 3 of 6 (50%) at TP53, 2 of 6 (33%) at D10S571, 3 of 6 (50%) at D16S507, 1 of 5 (20%) at D12S264, 0 of 6 (0%) at D17S855, 1 of 6 (17%) at D18S53, and 0 of 5 (0%) at D22S264. The pattern of allelic loss is significantly different in both stroma and epithelium statistically; completely concordant allelic loss patterns were not seen in any tumor examined. Our data demonstrate that both epithelial and stromal components of phyllodes tumor of the prostate are clonal, supporting the hypothesis that both elements are neoplastic. While both epithelium and stroma are clonal proliferations, they appear to have different clonal origins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466403      PMCID: PMC1618623          DOI: 10.1016/S0002-9440(10)63397-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

Review 1.  PCR techniques for clonality assays.

Authors:  S J Diaz-Cano; A Blanes; H J Wolfe
Journal:  Diagn Mol Pathol       Date:  2001-03

2.  Sex hormone metabolism in prostate cancer cells during transition to an androgen-independent state.

Authors:  Päivi Härkönen; Svea Törn; Riitta Kurkela; Katja Porvari; Anitta Pulkka; Aija Lindfors; Veli Isomaa; Pirkko Vihko
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

3.  Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components.

Authors:  E J Sawyer; A M Hanby; P Ellis; S R Lakhani; I O Ellis; S Boyle; I P Tomlinson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Molecular genetic evidence for different clonal origin of components of human renal angiomyolipomas.

Authors:  L Cheng; J Gu; J N Eble; D G Bostwick; C Younger; G T MacLennan; F W Abdul-Karim; W A Geary; M O Koch; S Zhang; T M Ulbright
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

5.  Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression.

Authors:  L Cheng; T M Pisansky; T J Sebo; B C Leibovich; D M Ramnani; A L Weaver; B G Scherer; M L Blute; H Zincke; D G Bostwick
Journal:  Clin Cancer Res       Date:  1999-10       Impact factor: 12.531

6.  p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression?

Authors:  L Cheng; B C Leibovich; E J Bergstralh; B G Scherer; A Pacelli; D M Ramnani; H Zincke; D G Bostwick
Journal:  Cancer       Date:  1999-06-01       Impact factor: 6.860

7.  Conserved genetic findings in metastatic bladder cancer: a possible utility of allelic loss of chromosomes 9p21 and 17p13 in diagnosis.

Authors:  L Cheng; D G Bostwick; G Li; S Zhang; A O Vortmeyer; Z Zhuang
Journal:  Arch Pathol Lab Med       Date:  2001-09       Impact factor: 5.534

8.  Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential.

Authors:  J Gu; L M Roth; C Younger; H Michael; F W Abdul-Karim; S Zhang; T M Ulbright; J N Eble; L Cheng
Journal:  J Natl Cancer Inst       Date:  2001-08-01       Impact factor: 13.506

9.  Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor.

Authors:  Liang Cheng; Jian Gu; Thomas M Ulbright; Gregory T MacLennan; Christopher J Sweeney; Shaobo Zhang; Katya Sanchez; Michael O Koch; John N Eble
Journal:  Cancer       Date:  2002-01-01       Impact factor: 6.860

10.  Phenotypic effects of overexpression of the MMAC1 gene in prostate epithelial cells.

Authors:  R M Sharrard; N J Maitland
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

View more
  13 in total

1.  Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer.

Authors:  Barbara Domazet; Gregory T Maclennan; Antonio Lopez-Beltran; Rodolfo Montironi; Liang Cheng
Journal:  Int J Clin Exp Pathol       Date:  2008-03-15

2.  Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.

Authors:  Daniella Bianchi-Frias; Ryan Basom; Jeffrey J Delrow; Ilsa M Coleman; Olga Dakhova; Xiaoyu Qu; Min Fang; Omar E Franco; Nolan G Ericson; Jason H Bielas; Simon W Hayward; Lawrence True; Colm Morrissey; Lisha Brown; Neil A Bhowmick; David Rowley; Michael Ittmann; Peter S Nelson
Journal:  Mol Cancer Res       Date:  2016-01-11       Impact factor: 5.852

Review 3.  Beyond laser microdissection technology: follow the yellow brick road for cancer research.

Authors:  Luc G Legres; Anne Janin; Christophe Masselon; Philippe Bertheau
Journal:  Am J Cancer Res       Date:  2014-01-15       Impact factor: 6.166

Review 4.  Laser capture microdissection: Big data from small samples.

Authors:  Soma Datta; Lavina Malhotra; Ryan Dickerson; Scott Chaffee; Chandan K Sen; Sashwati Roy
Journal:  Histol Histopathol       Date:  2015-04-20       Impact factor: 2.303

Review 5.  Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?

Authors:  Jones T Nauseef; Michael D Henry
Journal:  Nat Rev Urol       Date:  2011-06-21       Impact factor: 14.432

6.  Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma.

Authors:  Liang Cheng; Timothy D Jones; Ryan P McCarthy; John N Eble; Mingsheng Wang; Gregory T MacLennan; Antonio Lopez-Beltran; Ximing J Yang; Michael O Koch; Shaobo Zhang; Chong-Xian Pan; Lee Ann Baldridge
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

7.  Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.

Authors:  M J Bissell; P A Kenny; D C Radisky
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

Review 8.  Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe.

Authors:  Michael W Klymkowsky; Pierre Savagner
Journal:  Am J Pathol       Date:  2009-03-26       Impact factor: 4.307

9.  A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.

Authors:  Ashley Cimino-Mathews; Jessica L Hicks; Rajni Sharma; Russell Vang; Peter B Illei; Angelo De Marzo; Leisha A Emens; Pedram Argani
Journal:  Hum Pathol       Date:  2013-07-31       Impact factor: 3.466

10.  Recurrent prostatic stromal sarcoma with massive high-grade prostatic intraepithelial neoplasia.

Authors:  Teppei Morikawa; Akiteru Goto; Kyoichi Tomita; Yuzuri Tsurumaki; Satoshi Ota; Tadaichi Kitamura; Masashi Fukayama
Journal:  J Clin Pathol       Date:  2007-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.